BSN repricing to draw on US heat

EQT-owned German bandage maker BSN Medical (B/B2) is looking to reprice its €740m term loan ‘B’ at tighter terms just three months after signing, with leveraged finance bankers confident that the strength of the US loan market would make the adjustment possible.

  • 02 Oct 2012

BSN is looking to reduce the margin on the €455m euro-denominated tranche from 500bp to 425bp, and cut the margin on its €225m-equivalent US dollar tranche from 475bp to 325bp. The euro loans are offered at 99.5, with the dollar loans at par.

The Libor floors will remain at ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.

GlobalCapital European securitization league table

Rank Lead Manager/Arranger Total Volume $m No. of Deals Share % by Volume
1 Bank of America Merrill Lynch (BAML) 1,284 2 30.09
2 Barclays 633 1 14.82
3 BNP Paribas 509 1 11.91
4 Citi 467 1 10.94
5 Morgan Stanley 455 1 10.66

Bookrunners of Global Structured Finance

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 Citi 9,113.97 30 12.52%
2 Barclays 7,732.29 21 10.62%
3 Bank of America Merrill Lynch 7,473.95 24 10.26%
4 JPMorgan 7,225.34 25 9.92%
5 Wells Fargo Securities 6,258.35 24 8.59%